Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Parkinson's Disease

  Free Subscription


2 Ann Intern Med
2 Ann Neurol
1 Exp Brain Res
1 J Neural Transm (Vienna)
1 J Neurol Neurosurg Psychiatry
1 J Neurosci
5 Mov Disord
1 Nat Rev Neurol
3 Neurology
2 Neurosci Lett
1 Neuroscience
2 PLoS One
1 Science

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. Isradipine Versus Placebo in Early Parkinson Disease: A Randomized Trial.
    Ann Intern Med. 2020 Mar 31. pii: 2763874. doi: 10.7326/M19-2534.
    PubMed         Abstract available

  2. Isradipine Versus Placebo in Early Parkinson Disease.
    Ann Intern Med. 2020 Mar 31. pii: 2763974. doi: 10.7326/P20-0004.

    Ann Neurol

  3. WHITE DL, Kunik ME, Yu H, Lin HL, et al
    Post-traumatic stress disorder is associated with further increased Parkinson's disease risk in veterans with traumatic brain injury.
    Ann Neurol. 2020 Mar 30. doi: 10.1002/ana.25726.
    PubMed         Abstract available

  4. STROTZER QD, Anthofer JM, Faltermeier R, Brawanski AT, et al
    Deep brain stimulation: Connectivity profile for bradykinesia alleviation.
    Ann Neurol. 2019;85:852-864.
    PubMed         Abstract available

    Exp Brain Res

  5. PICKERING JS, Leroi I, McBride J, Poliakoff E, et al
    Continuous force measurements reveal no inhibitory control deficits in Parkinson's disease.
    Exp Brain Res. 2020 Mar 28. pii: 10.1007/s00221-020-05768.
    PubMed         Abstract available

    J Neural Transm (Vienna)

  6. MAGGI G, D'Iorio A, Di Meglio D, Vinciguerra A, et al
    The role of the motor subtypes on the relationship between anxiety and cognitive dysfunctions in Parkinson's disease.
    J Neural Transm (Vienna). 2020 Apr 1. pii: 10.1007/s00702-020-02179.
    PubMed         Abstract available

    J Neurol Neurosurg Psychiatry

  7. STOKER TB, Camacho M, Winder-Rhodes S, Liu G, et al
    A common polymorphism in SNCA is associated with accelerated motor decline in GBA-Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2020 Apr 2. pii: jnnp-2019-322210.

    J Neurosci

  8. SELLNOW RC, Steece-Collier K, Altwal F, Sandoval IM, et al
    Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    J Neurosci. 2020 Mar 27. pii: JNEUROSCI.2936-19.2020.
    PubMed         Abstract available

    Mov Disord

  9. KRISMER F, Seppi K, Gobel G, Steiger R, et al
    Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis.
    Mov Disord. 2019;34:1041-1048.
    PubMed         Abstract available

  10. HINKLE JT, Dawson VL, Dawson TM
    The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration.
    Mov Disord. 2019;34:959-969.
    PubMed         Abstract available

  11. LATORRE A, Rocchi L, Berardelli A, Bhatia KP, et al
    The interindividual variability of transcranial magnetic stimulation effects: Implications for diagnostic use in movement disorders.
    Mov Disord. 2019;34:936-949.
    PubMed         Abstract available

  12. PALMA JA
    Renal dysfunction might be a marker of cardiovascular dysautonomia in prodromal alpha-synucleinopathies.
    Mov Disord. 2020;35:374.

  13. VIEIRA SRL, Toffoli M, Campbell P, Schapira AHV, et al
    Biofluid Biomarkers in Parkinson's Disease: Clarity Amid Controversy.
    Mov Disord. 2020 Mar 27. doi: 10.1002/mds.28030.

    Nat Rev Neurol

  14. WOOD H
    Gene therapy boosts response to levodopa in patients with Parkinson disease.
    Nat Rev Neurol. 2020 Mar 31. pii: 10.1038/s41582-020-0351.


  15. PONTONE GM, Mills KA
    A call for better depression treatment in people with Parkinson disease.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009285.

  16. DOBKIN RD, Mann SL, Gara MA, Interian A, et al
    Telephone-based cognitive behavioral therapy for depression in Parkinson disease: A randomized controlled trial.
    Neurology. 2020 Apr 1. pii: WNL.0000000000009292.
    PubMed         Abstract available

  17. Retraction: High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease.
    Neurology. 2020 Mar 30. pii: WNL.0000000000009358.

    Neurosci Lett

  18. XU X, Xiong S, Zhou X, Chen X, et al
    SAP97 polymorphisms is associated with early onset Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134931. doi: 10.1016/j.neulet.2020.134931.
    PubMed         Abstract available

  19. KOSKI SK, Leino S, Panula P, Rannanpaa S, et al
    Genetic lack of histamine upregulates dopamine neurotransmission and alters rotational behavior but not levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Neurosci Lett. 2020 Mar 26:134932. doi: 10.1016/j.neulet.2020.134932.
    PubMed         Abstract available


  20. ALCOCK L, Galna B, Hausdorff JM, Lord S, et al
    Enhanced obstacle contrast to promote visual scanning in fallers with Parkinson's disease: Role of executive function.
    Neuroscience. 2020 Mar 25. pii: S0306-4522(20)30191.
    PubMed         Abstract available

    PLoS One

  21. LEE J, Lee AL, Park JH, Moon JE, et al
    The clinical application of nigrosome 1 detection on high-resolution susceptibility-weighted imaging in the evaluation of suspected Parkinsonism: The real-world performance and pitfalls.
    PLoS One. 2020;15:e0231010.
    PubMed         Abstract available

  22. Expression of Concern: Mucuna pruriens (Velvet bean) Rescues Motor, Olfactory, Mitochondrial and Synaptic Impairment in PINK1B9 Drosophila melanogaster Genetic Model of Parkinson's Disease.
    PLoS One. 2020;15:e0231371.


  23. GRASBY KL, Jahanshad N, Painter JN, Colodro-Conde L, et al
    The genetic architecture of the human cerebral cortex.
    Science. 2020;367.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.